The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

"Results from STEP UP further strengthen the clinical profile of semaglutide for the treatment ... with a 20.4% reduction in weight in the REDEFINE 1 study over 68 weeks that fell short of Novo ...

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

The MAGA meltdown after Tom Hanks played a racist Trump fan on Saturday Night Live’s 50th anniversary show now includes a ...

Kathy Davis of Canonsburg underwent heart surgery, but complications left her with right heart failure, a condition where the ...

Semaglutide mimics the GLP-1 hormone, naturally produced in the gut ... Weeks 12-20 After three or more months, you can expect visible weight loss. The STEP 2 trial found that volunteers lost 4% of ...

Endometrial cancer isn’t talked about much as much as it should be. It’s the most common cancer of the female reproductive ...